Case File №
#VI-2026-0262
Wolverine Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
38 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 5.0 | 5.0 | 5.0 | 3 Jul 2025 |
| AA Water | X N/A | 1 | 4.0 | 3.7 | 3.7 | 20 Jun 2025 |
| ACE-031 | X N/A | 1 | 4.6 | 4.6 | 4.6 | 13 Feb 2025 |
| AICAR | X N/A | 1 | 4.3 | 4.3 | 4.3 | 3 Jun 2025 |
| Anastrozole (Arimidex) Raw | X N/A | 1 | 4.0 | 3.2 | 3.2 | 2 Apr 2025 |
| BAM15 | X N/A | 1 | 4.5 | 4.5 | 4.5 | 9 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 4.0 | 3.5 | 3.5 | 13 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 2.7 | 2.7 | 13 Feb 2025 |
| Bronchogen | X N/A | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 |
| Cerebrolysin | X N/A | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.3 | 7.3 | 7.3 | 14 Jan 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 2.7 | 2.7 | 28 Mar 2025 |
| Crystagen | X N/A | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 |
| DNP | X N/A | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
| DSIP | X N/A | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 |
| EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | X N/A | 1 | 5.2 | 5.2 | 5.2 | 6 May 2025 |
| IGF-1 LR3 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 16 Mar 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.4 | 7.4 | 7.4 | 21 May 2025 |
| Letrozole | X N/A | 1 | 4.0 | 3.8 | 3.8 | 9 Jun 2025 |
| Lipo-C FOCUS 425mg | X N/A | 1 | 4.6 | 4.6 | 4.6 | 16 Mar 2025 |
| Masteron E (Drostanolone E) | X N/A | 1 | 4.0 | 3.7 | 3.7 | 8 Jul 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 |
| Methylstenbolone | X N/A | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 |
| Minoxidil Oral | X N/A | 1 | 4.0 | 3.4 | 3.4 | 27 Feb 2025 |
| MOTS-C | X N/A | 1 | 4.8 | 4.8 | 4.8 | 28 Mar 2025 |
| NAD+ Injectable | X N/A | 1 | 4.0 | 3.7 | 3.7 | 9 Jun 2025 |
| Oxytocin Acetate | X N/A | 1 | 4.6 | 4.6 | 4.6 | 8 Jul 2025 |
| P21 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 27 Feb 2025 |
| Prostamax | X N/A | 1 | 4.9 | 4.9 | 4.9 | 24 Apr 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.2 | 4.2 | 4.2 | 11 Jun 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 4.4 | 4.4 | 4.4 | 8 Jul 2025 |
| SLU-PP-332 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
| Sustanon Blend Raw | X N/A | 1 | 6.1 | 6.1 | 6.1 | 17 Dec 2024 |
| Test Cypionate | X N/A | 1 | 4.0 | 2.9 | 2.9 | 14 Jan 2025 |
| Tirzepatide 30mg Pen Kit | X N/A | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 |
| Tirzepatide Raw | X N/A | 1 | 5.1 | 5.1 | 5.1 | 28 Mar 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 5.8 | 5.8 | 5.8 | 21 May 2025 |
| Winstrol Water (Stanozolol) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 14 Jan 2025 |
Exhibit II
Evidence Log
38 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | NAD+ Injectable | 4.0 C | 200mg/ml | 228.3mg/ml | +14.2% | 97.80% | ee5tmn | Lab B | Public |
| 24 May 2026 | Lipo-C FOCUS 425mg | 4.0 C | 100mg/ml | 94.1mg/ml | -5.9% | 97.54% | 0fjq7h | Lab F | Public |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.4 B | 20mg | 19.8mg | -1.0% | 96.71% | cu32ko | Lab C | Public |
| 24 May 2026 | Oxytocin Acetate | 4.0 C | 5mg | 4.7mg | -6.6% | 96.09% | sxc1ka | Lab D | Public |
| 24 May 2026 | ACE-031 | 4.8 C | 30mg | 32.7mg | +9.0% | 95.53% | vic0gw | Lab E | Public |
| 24 May 2026 | IGF-1 LR3 | 6.4 A | 10mg | 11.9mg | +18.8% | 95.59% | voce9o | Lab F | Community |
| 24 May 2026 | Cerebrolysin | 5.9 B | 5mg | 4.8mg | -4.3% | 95.86% | yjdkj6 | Lab G | Public |
| 24 May 2026 | MENT (Trestolone Acetate) | 5.4 B | 200mg/ml | 206.3mg/ml | +3.1% | 99.09% | n6i2gr | Lab D | Public |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 4.3 C | 30mg | 30.9mg | +3.1% | 97.95% | ndyoli | Lab E | Community |
| 24 May 2026 | Test Cypionate | 6.4 A | 100mg/ml | 96.6mg/ml | -3.4% | 97.51% | nnhbl3 | Lab B | Public |
| 23 May 2026 | AA Water | 4.0 C | 5mg | 5.5mg | +9.3% | 98.19% | 5ynq9h | Lab G | Public |
| 20 May 2026 | BPC157 10mg + TB500 10mg Blend | 4.5 C | 2mg | 2.1mg | +3.5% | 99.89% | 2o1d2n | Lab E | Community |
| 19 May 2026 | Tirzepatide Raw | 4.0 C | 1g | 1.0g | -0.1% | 97.73% | abul0c | Lab D | Public |
| 17 May 2026 | Tirzepatide 30mg Pen Kit | 4.3 C | 15mg | 14.7mg | -2.1% | 98.67% | 17v6m9 | Lab F | Public |
| 29 Jan 2026 | Minoxidil Oral | 4.7 C | 20mg | 22.0mg | +10.0% | 97.01% | l02ffi | Lab D | Public |
| 29 Jan 2026 | MOTS-C | 4.2 C | 2mg | 2.4mg | +19.0% | 97.59% | b2nkdy | Lab D | Public |
| 26 Jan 2026 | Winstrol Water (Stanozolol) | 6.5 A | 200mg/ml | 218.2mg/ml | +9.1% | 98.65% | pf51b8 | Lab F | Public |
| 19 Jan 2026 | Vitamin B12 10mg/ml | 6.0 A | 250mg/ml | 257.4mg/ml | +3.0% | 96.07% | c6owx3 | Lab A | Community |
| 9 Jan 2026 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 6.3 A | 500g | 491.3g | -1.7% | 95.37% | 5m33h8 | Lab A | Community |
| 7 Jan 2026 | AICAR | 4.0 C | 30mg | 30.5mg | +1.8% | 95.55% | fwe6cs | Lab B | Community |
| 6 Jan 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 4.0 C | 20mg | 18.5mg | -7.6% | 98.47% | g5mc1n | Lab D | Public |
| 12 Dec 2025 | Crystagen | 6.1 A | 5mg | 4.9mg | -2.9% | 97.14% | sjprkt | Lab C | Public |
| 12 Dec 2025 | DNP | 5.5 B | 50mg | 50.0mg | +0.0% | 95.59% | prj0t1 | Lab B | Community |
| 12 Dec 2025 | Letrozole | 4.0 C | 50mg | 59.3mg | +18.6% | 95.86% | 947bfi | Lab G | Public |
| 12 Dec 2025 | Masteron E (Drostanolone E) | 4.0 C | 300mg/ml | 327.2mg/ml | +9.1% | 99.84% | k23hs9 | Lab D | Public |
| 5 Dec 2025 | Methylstenbolone | 6.9 A | 25mg | 30.7mg | +22.8% | 95.61% | rtvbxk | Lab E | Public |
| 5 Dec 2025 | Sustanon Blend Raw | 5.8 B | 1g | 1.2g | +15.2% | 98.20% | cwjkdr | Lab D | Community |
| 23 Nov 2025 | DSIP | 7.1 A | 30mg | 32.5mg | +8.2% | 97.33% | 53mf6k | Lab C | Community |
| 17 Nov 2025 | BAM15 | 4.1 C | 100mg | 85.4mg | -14.6% | 97.99% | 640hlu | Lab B | Community |
| 17 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 4.2 C | 30mg | 30.8mg | +2.6% | 99.51% | zjr5l8 | Lab E | Public |
| 14 Nov 2025 | Anastrozole (Arimidex) Raw | 5.2 B | 10g | 10.5g | +4.7% | 95.48% | jp7jsa | Lab G | Public |
| 5 Nov 2025 | Bronchogen | 9.3 A | 30mg | 28.8mg | -4.0% | 95.07% | wf4wxp | Lab F | Community |
| 17 Oct 2025 | P21 | 6.0 A | 10mg | 10.4mg | +4.3% | 95.93% | qpdaxm | Lab A | Public |
| 3 Oct 2025 | CJC-1295 With DAC | 9.6 A | 10mg | 11.5mg | +15.5% | 98.25% | okvgr5 | Lab D | Public |
| 3 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.8 A | 2mg | 2.2mg | +10.9% | 96.48% | uvoy9f | Lab F | Community |
| 3 Oct 2025 | Prostamax | 4.3 C | 50mg | 60.2mg | +20.4% | 99.81% | mefkx8 | Lab E | Public |
| 3 Oct 2025 | SLU-PP-332 | 6.6 A | 100mg | 116.5mg | +16.5% | 96.59% | qhle7e | Lab E | Public |
| 3 Jul 2025 | Retatrutide | 5.0 C | 10mg | 9.6mg | -4.0% | 97.49% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —